MRI in high risk women: benefits and problems.

Poster: "ECR 2013 / C-2466 / Magnetic resonance imaging (MRI) in high risk women: benefits and problems" by: "A. Pecchi, V. Marchesi, R. Battista, B. Canossi, L. Cortesi, P. Torricelli; Modena/IT"

[1]  Ellen Warner,et al.  Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination , 2004, JAMA.

[2]  J. Hopper,et al.  Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. , 2003, American journal of human genetics.

[3]  S. Heywang-Köbrunner,et al.  Multicenter Comparative Multimodality Surveillance of Women at Genetic-Familial High Risk for Breast Cancer (HIBCRIT Study): Interim Results , 2008 .

[4]  Constantine Gatsonis,et al.  Screening women at high risk for breast cancer with mammography and magnetic resonance imaging , 2005, Cancer.

[5]  J Chang-Claude,et al.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.

[6]  P. Porter,et al.  Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. , 2000, Journal of the National Cancer Institute.

[7]  S. Woolf,et al.  Breast Cancer Screening: A Summary of the Evidence for the U.S. Preventive Services Task Force , 2002, Annals of Internal Medicine.

[8]  G. Parmigiani,et al.  Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutations , 2004, European Journal of Human Genetics.

[9]  R. Warren,et al.  Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) , 2005, The Lancet.

[10]  S. Venuta,et al.  An oncologist-based model of cancer genetic counselling for hereditary breast and ovarian cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  J. Benichou,et al.  Epidemiology and Biostatistics Program of the National Cancer Institute , 1994 .

[12]  S. Pinder,et al.  Breast imaging findings in women with BRCA1- and BRCA2-associated breast carcinoma. , 2004, Clinical radiology.

[13]  D. Miglioretti,et al.  Erratum: Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography (Annals of Internal Medicine (2003) 138 (168-175)) , 2003 .

[14]  H. D. de Koning,et al.  Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. , 2004, The New England journal of medicine.

[15]  L. Cortesi,et al.  Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experience , 2006, BMC Cancer.

[16]  Maximilian Reiser,et al.  Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  M. Federico,et al.  Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal , 1999, Breast Cancer Research and Treatment.

[18]  M. Urioste,et al.  The Average Cumulative Risks of Breast and Ovarian Cancer for Carriers of Mutations in BRCA1 and BRCA2 Attending Genetic Counseling Units in Spain , 2008, Clinical Cancer Research.

[19]  R. Fimmers,et al.  Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  M. Leach.  Breast cancer screening in women at high risk using MRI , 2009, NMR in biomedicine.

[21]  N. Risch,et al.  The calculation of breast cancer risk for women with a first degree family history of ovarian cancer , 1993, Breast Cancer Research and Treatment.

[22]  Laura Cortesi,et al.  Multicenter Surveillance of Women at High Genetic Breast Cancer Risk Using Mammography, Ultrasonography, and Contrast-Enhanced Magnetic Resonance Imaging (the High Breast Cancer Risk Italian 1 Study): Final Results , 2011, Investigative radiology.